Joshua James Wheeler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joshua James Wheeler has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Santosh Kumar Mishra
North Carolina State University
5 shared publications - Anthony F. Domenichiello
Lipid Peroxidation Unit, Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, USA
2 shared publications - Christopher E. Ramsden
Lipid Peroxidation Unit, Laboratory of Clinical Investigation, National Institute on Aging, NIH 251 Bayview Blvd., Baltimore, MD, 21224, USA
2 shared publications - Gregory S. Keyes
Lipid Peroxidation Unit, Laboratory of Clinical Investigation, National Institute on Aging
2 shared publications - John M. Davis
Psychiatric Institute, University of Illinois at Chicago, Chicago, IL, USA; Maryland Psychiatric Research Center, Baltimore, MD, USA
2 shared publications Nidha Williams
Molecular Biomedical Sciences, NC State College of Veterinary Medicine, NC State University, Raleigh, USA
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 1393
Metabolic sensor Gpr35 links dietary lipids to itch mediating neural circuits
- 29 October 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 1393
Open AccessMetabolic sensor Gpr35 links dietary lipids to itch mediating neural circuits
- Open Access
- 2 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Substance P and somatostatin neurons limit facial itch by recruiting distinct nociceptive circuits in the brainstem
Itch is a complex noxious sensation associated with many skin and systemic conditions, which varies in intensity and quality across different body regions. Despite its prevalence, the molecular and cellular mechanisms underlying regional itch differences remain poorly understood. Investigating the neural basis of regional itch differences, we identified a functional divergence in neuropeptide signaling and central circuit engagement between the trigeminal and spinal systems, which was independent of peripheral innervation density. Utilizing a combination of behavioral, pharmacological, genetic, and molecular assays, we identified a unique population of trigeminal (TG) neurons that facilitate specialized itch-pain coding. Our results indicate that while histamine receptors HRH1 and HRH3 are both involved in mediating mixed itch-and-pain sensations, the specific activity of Substance P (SP)- and Somatostatin (SST)-expressing neurons orchestrates this transition in the cheek. This behavioral shift is mediated by a central mechanism wherein sensory neurons activation recruits distinct nociceptive circuits within the brainstem. In brief, these findings provide insights into the molecular and cellular mechanisms underlying regional itch differences, highlighting the importance of considering anatomical location when developing targeted treatments.
- 2 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessSubstance P and somatostatin neurons limit facial itch by recruiting distinct nociceptive circuits in the brainstem
Itch is a complex noxious sensation associated with many skin and systemic conditions, which varies in intensity and quality across different body regions. Despite its prevalence, the molecular and cellular mechanisms underlying regional itch differences remain poorly understood. Investigating the neural basis of regional itch differences, we identified a functional divergence in neuropeptide signaling and central circuit engagement between the trigeminal and spinal systems, which was independent of peripheral innervation density. Utilizing a combination of behavioral, pharmacological, genetic, and molecular assays, we identified a unique population of trigeminal (TG) neurons that facilitate specialized itch-pain coding. Our results indicate that while histamine receptors HRH1 and HRH3 are both involved in mediating mixed itch-and-pain sensations, the specific activity of Substance P (SP)- and Somatostatin (SST)-expressing neurons orchestrates this transition in the cheek. This behavioral shift is mediated by a central mechanism wherein sensory neurons activation recruits distinct nociceptive circuits within the brainstem. In brief, these findings provide insights into the molecular and cellular mechanisms underlying regional itch differences, highlighting the importance of considering anatomical location when developing targeted treatments.
- Open Access
- 26 May 2025
- Published by Springer Nature in Research Square
The Molecular and Cellular Basis of Regional Itch Differences
Itch is a complex, noxious sensation associated with many skin and systemic conditions, which varies in intensity and quality across different body regions. Despite its prevalence, the molecular and cellular mechanisms underlying regional itch differences remain poorly understood. Here, we investigate the neural basis of regional itch differences, focusing on the role of neuropeptides and histamine receptors expression. Using a combination of behavioral, pharmacological, genetic, histological, and molecular approaches, we identified distinct regional differences in itch response between the cheek and dorsal nape (neck). Our findings reveal that Substance P modulates itch in the cheek, while histamine receptor 1 (HRH1) is the primary receptor mediating itch but not pain in the cheek. We also discovered regional differences in sensory neuron subpopulations, with increased co-expression of HRH1 and neuropeptides in trigeminal ganglion neurons. In brief, we provide new insights into the molecular and cellular mechanisms underlying regional itch differences, highlighting the importance of considering regional variations in itch response to develop effective treatments.
- 26 May 2025
- Published by Springer Nature in Research Square
Open AccessThe Molecular and Cellular Basis of Regional Itch Differences
Itch is a complex, noxious sensation associated with many skin and systemic conditions, which varies in intensity and quality across different body regions. Despite its prevalence, the molecular and cellular mechanisms underlying regional itch differences remain poorly understood. Here, we investigate the neural basis of regional itch differences, focusing on the role of neuropeptides and histamine receptors expression. Using a combination of behavioral, pharmacological, genetic, histological, and molecular approaches, we identified distinct regional differences in itch response between the cheek and dorsal nape (neck). Our findings reveal that Substance P modulates itch in the cheek, while histamine receptor 1 (HRH1) is the primary receptor mediating itch but not pain in the cheek. We also discovered regional differences in sensory neuron subpopulations, with increased co-expression of HRH1 and neuropeptides in trigeminal ganglion neurons. In brief, we provide new insights into the molecular and cellular mechanisms underlying regional itch differences, highlighting the importance of considering regional variations in itch response to develop effective treatments.
- 11 October 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (3) , 705-707
Brain Natriuretic Peptide Exerts Inflammation and Peripheral Itch in a Mouse Model of Atopic Dermatitis
- 11 October 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (3) , 705-707
Brain Natriuretic Peptide Exerts Inflammation and Peripheral Itch in a Mouse Model of Atopic Dermatitis
- Open Access
- 26 December 2022
- Published by Elsevier in JID Innovations
- Vol. 3 (2) , 100177
Endogenous Derivatives of Linoleic Acid and their Stable Analogs Are Potential Pain Mediators
- 26 December 2022
- Published by Elsevier in JID Innovations
- Vol. 3 (2) , 100177
Open AccessEndogenous Derivatives of Linoleic Acid and their Stable Analogs Are Potential Pain Mediators
- 22 August 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 10 (493)
A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch
Chronic pain and itch are common hypersensitivity syndromes that are affected by endogenous mediators. We applied a systems-based, translational approach to predict, discover, and characterize mediators of pain and itch that are regulated by diet and inflammation. Profiling of tissue-specific precursor abundance and biosynthetic gene expression predicted that inflamed skin would be abundant in four previously unknown 11-hydroxy-epoxy- or 11-keto-epoxy-octadecenoate linoleic acid derivatives and four previously identified 9- or 13-hydroxy-epoxy- or 9- or 13-keto-epoxy-octadecenoate linoleic acid derivatives. All of these mediators were confirmed to be abundant in rat and human skin by mass spectrometry. However, only the two 11-hydroxy-epoxy-octadecenoates sensitized rat dorsal root ganglion neurons to release more calcitonin gene–related peptide (CGRP), which is involved in pain transmission, in response to low pH (which mimics an inflammatory state) or capsaicin (which activates ion channels involved in nociception). The two 11-hydroxy-epoxy-octadecenoates share a 3-hydroxy-Z-pentenyl-E-epoxide moiety, thus suggesting that this substructure could mediate nociceptor sensitization. In rats, intradermal hind paw injection of 11-hydroxy-12,13-trans-epoxy-(9Z)-octadecenoate elicited C-fiber–mediated sensitivity to thermal pain. In a randomized trial testing adjunctive strategies to manage refractory chronic headaches, reducing the dietary intake of linoleic acid was associated with decreases in plasma 11-hydroxy-12,13-trans-epoxy-(9Z)-octadecenoate, which correlated with clinical pain reduction. Human psoriatic skin had 30-fold higher 9-keto-12,13-trans-epoxy-(10E)-octadecenoate compared to control skin, and intradermal injection of this compound induced itch-related scratching behavior in mice. Collectively, these findings define a family of endogenous mediators with potential roles in pain and itch.
- 22 August 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 10 (493)
A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch
Chronic pain and itch are common hypersensitivity syndromes that are affected by endogenous mediators. We applied a systems-based, translational approach to predict, discover, and characterize mediators of pain and itch that are regulated by diet and inflammation. Profiling of tissue-specific precursor abundance and biosynthetic gene expression predicted that inflamed skin would be abundant in four previously unknown 11-hydroxy-epoxy- or 11-keto-epoxy-octadecenoate linoleic acid derivatives and four previously identified 9- or 13-hydroxy-epoxy- or 9- or 13-keto-epoxy-octadecenoate linoleic acid derivatives. All of these mediators were confirmed to be abundant in rat and human skin by mass spectrometry. However, only the two 11-hydroxy-epoxy-octadecenoates sensitized rat dorsal root ganglion neurons to release more calcitonin gene–related peptide (CGRP), which is involved in pain transmission, in response to low pH (which mimics an inflammatory state) or capsaicin (which activates ion channels involved in nociception). The two 11-hydroxy-epoxy-octadecenoates share a 3-hydroxy-Z-pentenyl-E-epoxide moiety, thus suggesting that this substructure could mediate nociceptor sensitization. In rats, intradermal hind paw injection of 11-hydroxy-12,13-trans-epoxy-(9Z)-octadecenoate elicited C-fiber–mediated sensitivity to thermal pain. In a randomized trial testing adjunctive strategies to manage refractory chronic headaches, reducing the dietary intake of linoleic acid was associated with decreases in plasma 11-hydroxy-12,13-trans-epoxy-(9Z)-octadecenoate, which correlated with clinical pain reduction. Human psoriatic skin had 30-fold higher 9-keto-12,13-trans-epoxy-(10E)-octadecenoate compared to control skin, and intradermal injection of this compound induced itch-related scratching behavior in mice. Collectively, these findings define a family of endogenous mediators with potential roles in pain and itch.